Product Information

VENLAFAXINE HCL ER 37.5 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.3318 per EA under NDC 70710134803. Its NADAC has been published 205 times since Dec 21, 2022.

FDA first approved this application on Aug 30, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VENLAFAXINE HCL ER 37.5 MG TAB

Venlafaxine
$0.3318per EA

Strength

37.5 mg/1

NDC

70710134803

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

VENLAFAXINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215622

FDA Approved

8/30/2022

TE Code

AB

On Market Since

9/1/2022

Pharmacological Classes

Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for VENLAFAXINE HCL ER 37.5 MG TAB has been published 205 times since Dec 21, 2022, and over the history we have for it it has declined 83.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3318 per EA
All-time high$2.0495 (Mar 15, 2023)
All-time low$0.3039 (Jan 22, 2025)
52-week high$0.5169
52-week low$0.3048
Median price$0.5044
Average price$0.6983
Largest weekly change-56.8% (Apr 17, 2024)
Weeks tracked205
Tracking sinceDec 21, 2022

Price History

1W

+8.9%

1M

-7.3%

3M

-28.2%

6M

-22.1%

1Y

-28.0%

3Y

-60.5%

5Y

N/A

All

-83.8%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of VENLAFAXINE HCL ER 37.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 37.5 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.3318 per EA (NDC 70710134803), effective Nov 18, 2026.

How has the price of VENLAFAXINE HCL ER 37.5 MG TAB changed over time?

Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 37.5 MG TAB has declined 83.8%. It has been tracked across 205 weekly CMS publications since Dec 21, 2022.

What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 37.5 MG TAB?

Since Dec 21, 2022, the NADAC for VENLAFAXINE HCL ER 37.5 MG TAB has ranged from a low of $0.3039 (Jan 22, 2025) to a high of $2.0495 (Mar 15, 2023), with a median of $0.5044 per EA.

Are there cheaper alternatives to VENLAFAXINE HCL ER 37.5 MG TAB?

Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VENLAFAXINE HCL 37.5 MG TABLET, is $0.0798 per EA — about 76% below VENLAFAXINE HCL ER 37.5 MG TAB.

Who manufactures VENLAFAXINE HCL ER 37.5 MG TAB?

VENLAFAXINE HCL ER 37.5 MG TAB (NDC 70710134803) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.